Remote Possibilities

By Andrew Karp
Monday, June 10, 2019 12:30 AM Many different forms of ocular telemedicine—also referred to as ocular telehealth—have emerged in the past few years. They create a dynamic but fragmented market in which different business models and service offerings compete for consumer dollars and buy-in from eyecare professionals. The proliferation of ocular telehealth options and the growing investment in the category leaves little doubt that it is gaining momentum, VM has learned for this special Megatrend report.

Center for Vision and Population Health at Prevent Blindness Appoints New Advisory Committee Members

By Staff
Wednesday, May 22, 2019 12:18 AM CHICAGO—Prevent Blindness, has announced the appointment of its new Advisory Committee members for the Center for Vision and Population Health at Prevent Blindness (CVPH). The CVPH was established in December 2018 as a national coordinating body for effective practices, state-level technical assistance, and programmatic interventions. This month, the CVPH convened the full membership of the Advisory Committee in Chicago for the first time, led by committee chair Heather E. Whitson, MD, MHS, associate professor of medicine, associate professor in ophthalmology, and deputy director of the Center for the Study of Aging and Human Development at Duke University.

World Council of Optometry and Brien Holden Vision Institute Collaborate for Myopia Awareness Week, May 13 to 19

By Staff
Wednesday, May 8, 2019 12:18 AM LAKEWOOD, Colo.—Myopia Awareness Week will be May 13 to 19, and is designed to build awareness about myopia among eyecare professionals and to inspire action in caregivers to protect their children's vision. The World Council of Optometry and the Brien Holden Vision Institute are collaborating on the initiative and encouraging others to join in. “We know that almost half the world’s population will be myopic by the year 2050, with nearly one billion people in the high myopia category. Myopia Awareness Week is about getting people talking about myopia in homes and optometry practices around the world,” stated WCO president, Dr Scott Mundle.

Essilor Partners With Groupe Renault to Promote Importance of Good Vision for Road Safety

By Staff
Tuesday, May 7, 2019 12:15 AM PARIS-CHARENTON—To honor the United Nations’ fifth annual Road Safety Week, Essilor and Groupe Renault have announced their joint signing of a Memorandum of Understand (MOU) for two years, with the goal of together raising awareness about how good vision is related to road safety, as well as to explore innovative solutions that will improve drivers’ visual experiences. According to Essilor, research shows that 1 in 5 drivers worldwide has uncorrected poor vision. Since 90 percent of the information needed to drive comes from the eyes, this can make driving extremely dangerous.

Prevent Blindness Names May UV Awareness Month for 2019

By Staff
Tuesday, April 30, 2019 12:24 AM CHICAGO—Prevent Blindness has declared May UV Awareness Month. The goal is both to educate the public about the dangers of UV exposure to our eyes, and to provide information on how people can protect themselves. According to Prevent Blindness, everyone should wear both sunglasses and a brimmed hat while outside. UV damage to the eyes has been linked to the development of macular degeneration, cataract, and cancer, and can cause corneal sunburn.

April Is Women’s Eye Health and Safety Awareness Month

By Stephanie Sengwe
Friday, April 26, 2019 10:43 AM With Women’s History Month behind us and Mother’s Day right around the corner, Prevent Blindness has continued to show some love to the ladies by reminding them to take care of their eyesight this month. The organization declared April as Women’s Eye Health and Safety Awareness Month to highlight the different needs in addressing women’s eye health. According to Prevent Blindness, women often make the majority of their family's health care decisions; in addition to being responsible for their own health, women are often responsible as caregivers for the health care choices of their children, partners, spouse and aging parents.

Presby-What? New Alcon Survey Shows Patients' Knowledge Gaps About Presbyopia

By Staff
Wednesday, April 24, 2019 12:15 AM
FORT WORTH, Texas—Alcon has initiated a program this month to educate consumers about presbyopia, a condition that is expected to impact 123 million U.S. residents by 2020. Most ECPs know that presbyopia is the inability of the eye to focus on things up close, a natural part of aging that usually happens around age 40. However, new survey findings from Alcon show this common condition has a name people often do not recognize, symptoms they do not understand, and a lack of knowledge of vision correction options other than reading glasses that many see as inconvenient.

Johnson & Johnson Posts Sales Increase in 1Q 2019

By Staff
Wednesday, April 17, 2019 12:21 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) reported sales of $20.02 billion for the first quarter ended March 31, 2019, reflecting growth of 0.1 percent, operational growth of 3.9 percent and adjusted operational growth of 5.5 percent increase. The increases were driven in part by strong sales of Acuvue contact lenses by its vision business, J&J said. The health care conglomerate said net profit fell to $3.75 billion from $4.37 billion in the prior year. “Our strong first-quarter results reflect continued underlying operational sales and adjusted earnings per share (EPS) growth,” said Alex Gorsky, chairman and CEO.

NCCVEH at Prevent Blindness Names First Partners in ‘Better Vision Together-Community of Practice’ Program

By Staff
Wednesday, April 17, 2019 12:18 AM CHICAGO—The National Center for Children’s Vision and Eye Health at Prevent Blindness (NCCVEH) has announced the first partners of its “Better Vision Together-Community of Practice” program. According to a release, the goal of this project is to improve vision and eye health in at-risk, minority and vulnerable populations of young children. The NCCVEH will work with selected groups to provide aid and solutions that are rooted in population health strategies through a peer-support approach. These include policy change, systems of vision and eye health, public awareness, and data collection.

RightEye Offers Researchers a Database to Track Neurological Conditions

By Staff
Wednesday, April 3, 2019 12:15 AM BETHESDA, Md.—RightEye announced that it has built an extensive database that is being used by major research and health institutions to examine the eye-brain connection and detect the early onset of neurological conditions such as Parkinson’s Disease. The database was built using more than one billion data points from over 100,000 patient tests conducted with RightEye’s eye-tracking system. The anonymized data, which RightEye expects to exceed two billion data points by year end, is providing researchers with a new and deeper understanding of early indicators for neurological issues, which are anticipated to help in the development of new treatment options and interventions, the company said.

RightEye Offers Researchers a Database to Track Neurological Conditions

By Staff
Tuesday, April 2, 2019 9:00 AM BETHESDA, Md.—RightEye announced that it has built an extensive database that is being used by major research and health institutions to examine the eye-brain connection and detect the early onset of neurological conditions such as Parkinson’s Disease. The database was built using more than one billion data points from over 100,000 patient tests conducted with RightEye’s eye-tracking system. The anonymized data, which RightEye expects to exceed two billion data points by year end, is providing researchers with a new and deeper understanding of early indicators for neurological issues, which are anticipated to help in the development of new treatment options and interventions, the company said.

New Research Projects Larger Dramatic Rise in Myopia Among Children Around the World at First Sightgeist Conference

By Staff
Tuesday, April 2, 2019 12:24 AM LONDON—Clearly, a global charity tackling the issue of poor vision has highlighted the dramatic rise of myopia among children around the world, with figures set to increase from an already worrying 300 million children today to 500 million by 2050. The revised data was featured at the start of Sightgeist a one-day event held here set up by Clearly founder James Chen on March 28, uniting many stakeholders and organizations working to address unmet vision care access around the world.

Alcon Acquires IOL Lens Development Company PowerVision Inc.

By Staff
Tuesday, March 19, 2019 12:30 AM FORT WORTH, Texas—Alcon, a global leader in eyecare, said Monday it has acquired PowerVision Inc., a privately-held, U.S.-based medical device development company focused on creating fluid-based intraocular lens implants. Alcon said the acquisition furthers its commitment to drive growth and innovation in advanced technology intraocular lenses (AT-IOLS) to meet the needs of cataract surgery patients who desire spectacle independence. “As the industry leader in cataract surgery, we’re eager to accelerate development of this potentially breakthrough accommodating lens technology,” said Alcon’s Michael Onuscheck, president of global business and innovation.

California Optometric Association Helps Diabetes Patients Connect With Health Care

By Staff
Wednesday, February 20, 2019 12:15 AM SACRAMENTO, Calif.—A recent California Health Policy Strategies policy brief finds that the partnership between the California Optometric Association (COA), Anthem Blue Cross Medi-Cal Health Plan, and community health centers throughout California was successful in connecting diabetes patients with comprehensive care. In this partnership, Anthem Blue Cross Medi-Cal Health Plan reached out to its members with a history of diabetes who had not accessed recommended health screenings, and invited them to the Diabetes Day Clinic at a local health center.

Janssen Enters Collaboration Agreement With MeiraGTx to Develop Programs for Inherited Retinal Diseases

By Staff
Tuesday, February 12, 2019 12:15 AM RARITAN, N.J.—The Janssen unit of Johnson & Johnson has announced a worldwide collaboration and license agreement with MeiraGTx Holdings (NASDAQ:MGTX), a clinical-stage gene therapy company, to develop, manufacture and commercialize its clinical stage inherited retinal disease portfolio. The portfolio includes leading product candidates for achromatopsia (ACHM) caused by mutations in either CNGB3 or CNGA3, and X-linked retinitis pigmentosa (XLRP). Further, the companies have formed a research collaboration to explore new targets for other inherited retinal diseases and further develop adeno-associated virus (AAV) manufacturing technology, according to an announcement.